ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,535
Screening encounters
4,113
Diagnostic referrals
783
Outstanding pathways
282

Screening pathway

  1. Screening4,113Encounters
  2. Positive finding1,406Documented findings
  3. Referral783Diagnostic referrals
  4. Follow-up920Diagnostic visits
  5. Outcome501Resolved pathways

Stage totals use different units. Pending pathways: 282. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-09-23, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3535 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3548 · Expanded synthetic participant 3548Site E — Resource-Constrained Navigation Programme
EXP-3549 · Expanded synthetic participant 3549Site D — Community Engagement Programme
EXP-3550 · Expanded synthetic participant 3550Site D — Community Engagement Programme
EXP-3551 · Expanded synthetic participant 3551Site C — Rural Outreach Programme
EXP-3554 · Expanded synthetic participant 3554Site E — Resource-Constrained Navigation Programme
EXP-3555 · Expanded synthetic participant 3555Site E — Resource-Constrained Navigation Programme
EXP-3556 · Expanded synthetic participant 3556Site A — Urban Referral Hub
EXP-3557 · Expanded synthetic participant 3557Site C — Rural Outreach Programme
EXP-3558 · Expanded synthetic participant 3558Site A — Urban Referral Hub
EXP-3559 · Expanded synthetic participant 3559Site D — Community Engagement Programme
EXP-3563 · Expanded synthetic participant 3563Site C — Rural Outreach Programme
EXP-3564 · Expanded synthetic participant 3564Site D — Community Engagement Programme
EXP-3565 · Expanded synthetic participant 3565Site A — Urban Referral Hub
EXP-3566 · Expanded synthetic participant 3566Site A — Urban Referral Hub
EXP-3567 · Expanded synthetic participant 3567Site A — Urban Referral Hub
EXP-3568 · Expanded synthetic participant 3568Site D — Community Engagement Programme
EXP-3570 · Expanded synthetic participant 3570Site B — Peri-Urban Access Programme
EXP-3571 · Expanded synthetic participant 3571Site D — Community Engagement Programme
EXP-3572 · Expanded synthetic participant 3572Site B — Peri-Urban Access Programme
EXP-3573 · Expanded synthetic participant 3573Site B — Peri-Urban Access Programme
EXP-3574 · Expanded synthetic participant 3574Site A — Urban Referral Hub
EXP-3575 · Expanded synthetic participant 3575Site E — Resource-Constrained Navigation Programme
EXP-3576 · Expanded synthetic participant 3576Site E — Resource-Constrained Navigation Programme
EXP-3580 · Expanded synthetic participant 3580Site A — Urban Referral Hub
EXP-3581 · Expanded synthetic participant 3581Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
1607
HPV DNA
1923
Cytology
583

Navigation activity

Barrier documented
692
Contact attempt
1151
Navigation intervention
293
Diagnostic booking
969
Diagnostic visit
920

Documented barriers

Contact difficulty
224
Transport difficulty
224
Appointment coordination
244

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.